» Articles » PMID: 8180411

The Role of Endothelium in the Pathogenesis of Diabetic Microangiopathy

Overview
Journal Acta Diabetol
Specialty Endocrinology
Date 1993 Jan 1
PMID 8180411
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Damage caused to the vessel wall by diverse mechanisms may lead to diabetic microangiopathy. Consequently, research work is more and more focusing on the pathophysiology of vascular cells, with particular emphasis on endothelium. This paper reviews the present knowledge on the alterations of small vessel endothelium in diabetes. The most important risk factors for diabetic microangiopathy are the duration of disease and the degree of metabolic control maintained throughout the years. However, genetic factors may also contribute. These are examined first, followed by the presumed roles played by increased protein glycation and the production of Advanced Glycosylation End Products, the "polyol pathway" and free radical generation. Endothelium is a widespread, extremely active organ which regulates complex physiologic functions and its structure and function are discussed in the second section of this review. The third part deals with how diabetes can affect endothelium and describes observations on endothelial metabolism in vitro as well as morphologic and functional alterations in the patients. Unfortunately, the mechanisms leading to progressive degeneration of the microcirculation and organ damage in diabetic patients remain largely unaccounted for.

Citing Articles

NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies.

Rezaee A, Rahmanian P, Nemati A, Sohrabifard F, Karimi F, Elahinia A Heliyon. 2024; 10(9):e29871.

PMID: 38707342 PMC: 11066643. DOI: 10.1016/j.heliyon.2024.e29871.


Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases.

Li R, Huang W Int J Mol Sci. 2023; 24(2).

PMID: 36675179 PMC: 9861006. DOI: 10.3390/ijms24021666.


Endothelial Dysfunction and Diabetic Cardiomyopathy.

Wang M, Li Y, Li S, Lv J Front Endocrinol (Lausanne). 2022; 13:851941.

PMID: 35464057 PMC: 9021409. DOI: 10.3389/fendo.2022.851941.


Effects of Momordica charantia L. on the blood rheological properties in diabetic patients.

Franca E, Ribeiro E, Scherer E, Cantarini D, Pessoa R, Franca F Biomed Res Int. 2014; 2014:840379.

PMID: 24672797 PMC: 3930187. DOI: 10.1155/2014/840379.


Endothelium: the main actor in the remodelling of the retinal microvasculature in diabetes.

Porta M Diabetologia. 1996; 39(6):739-44.

PMID: 8781772 DOI: 10.1007/BF00418548.


References
1.
Dobrina A, Rossi F . Metabolic properties of freshly isolated bovine endothelial cells. Biochim Biophys Acta. 1983; 762(2):295-301. DOI: 10.1016/0167-4889(83)90084-8. View

2.
Takahashi K, Ghatei M, Lam H, OHalloran D, Bloom S . Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 1990; 33(5):306-10. DOI: 10.1007/BF00403325. View

3.
Bollinger A, Frey J, Jager K, Furrer J, Seglias J, Siegenthaler W . Patterns of diffusion through skin capillaries in patients with long-term diabetes. N Engl J Med. 1982; 307(21):1305-10. DOI: 10.1056/NEJM198211183072103. View

4.
Porta M, Maneschi F, White M, Kohner E . Twenty-four hour variations of von Willebrand factor and factor VIII-related antigen in diabetic retinopathy. Metabolism. 1981; 30(7):695-9. DOI: 10.1016/0026-0495(81)90085-8. View

5.
Pirart J . [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (author's transl)]. Diabete Metab. 1977; 3(2):97-107. View